Memphasys Limited: Director Appointment and Resignation
(firmenpresse) - 13 March 2020 - Australian-based bio-separations company Memphasys Limited (ASX: MEM) (Memphasys or the Company) wishes to advise the appointment of Mr Paul Wright as an independent non-executive director, effective immediately.
With more than 30 years experience as a highly skilled executive in strategic consulting and the development and sales of innovative medical devices and diagnostic tools, Mr Wright is well positioned to assist Memphasys in the commercialisation of its Felix device.
Mr Wrights background includes developing and implementing commercialisation strategies from early research and development through to developing global product sales channels. He has experience in building distribution partnerships and the direct selling and marketing of highly innovative products internationally.
In his early career, Mr Wright worked with business strategy consulting firm Bain & Company in Europe, North America and Asia, advising multinational clients on growth strategy, mergers and acquisitions and operations management.
For the past two decades, Mr Wright worked as CEO for three leading international Australian technology companies focussed on developing, manufacturing and marketing of medical devices and diagnostic instruments, including: Invetech and Vision BiosSystems, which were acquired by a Fortune 500 company and Universal Biosensors, where Mr Wright developed commercial partnerships with two large multinationals and oversaw the development, commercialisation and manufacturing scale-up of a blood coagulation analyser for world markets.
Mr Wright is currently a non-executive director of design, engineering and technology commercialisation company Hydrix Ltd and an advisory board member for unlisted digital wastewater services company, Waterwerx Pty Ltd.
He holds a Masters degree in Engineering from Cambridge University, UK and is a Fellow of the Australian Institute of Company Directors.
Resignation of Marjan Mikel
The Company has received the resignation of non-executive director Marjan Mikel, effective immediately. Mr Mikel has elected to step down from the Board to focus his full attention on his new position of CEO and Managing Director of ASX-listed biotechnology company Respiri Limited.
Mr Mikel has provided strong support to Memphasys during a period which has seen significant development of its Felix device.
Commenting on the changes to the Board, Memphasys Executive Chair Ms Alison Coutts said:
I am thrilled to be able to announce the appointment of Paul Wright as a non-executive director. It is incredibly rare to find an Australian company director with such a strong skill set in not only medical product development and manufacturing, but also commercialisation, business strategy and international distribution.
The appointment of Mr Wright occurs at a pivotal time for Memphasys with the Felix device fast approaching commercial sales.
I would also like to thank Marjan for his services at the Company as he has played an important role in the Companys development. We wish him well in his future endeavours.
ENDS
This announcement has been approved for release by the board of Memphasys Limited.
For further information please contact:
Alison Coutts
Executive Chairman
Memphasys Limited
T: +61 2 8415 7300
E:alison.coutts(at)memphasys.com
David Tasker
Managing Director
Chapter One Advisors
T: +0433 112 936
E: dtasker(at)chapteroneadvisors.com.au
About Memphasys:
Memphasys Limited (ASX: MEM) specialises in biological separations for high value commercial applications. The Companys patented membrane processes in combination with electrophoresis, the application of an electrical potential difference across a fluid, enable the separation of high value substances or contaminants from the fluid in which they are contained.
The main application of the technology is the separation of the most viable sperm cells for artificial reproduction, most particularly for human IVF.
Website: www.memphasys.com
Leseranfragen:
Datum: 13.03.2020 - 09:33 Uhr
Sprache: Deutsch
News-ID 608956
Anzahl Zeichen: 4398
contact information:
Town:
Wien
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 219 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Memphasys Limited: Director Appointment and Resignation
"
steht unter der journalistisch-redaktionellen Verantwortung von
Memphasys Limited (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
